Skip to main content

People in the News: Oct 27, 2011 (rev. 1)

Premium

Quidel said this week that John Radak will be stepping down from his role as CFO, and that Randy Steward will be taking his place effective Oct. 31.

Steward previously served as CFO for medical device company Navilyst. He has also served as COO for SeQual Technologies in San Diego, and executive vice president and CFO at Spectrum Brands.


Bernd Brust has resigned as president of molecular medicine at Life Technologies to pursue other opportunities, the company said in a filing with the US Securities and Exchange Commission this week.

Brust has led the molecular medicine business unit since January, when it was created to help the company transition next-gen sequencing into the clinic. He previously served as Life Tech's president of commercial operations.

Life Tech said that Brust will continue to serve as a consultant through Dec. 31 "to assist the company with various endeavors."

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.